December 2024 Third, we have finalized the prot
Post# of 152429
(Total Views: 449)
Posted On: 05/06/2025 2:28:05 PM
December 2024
Quote:
Third, we have finalized the protocol for a pilot study of leronlimab in the treatment of patients with mild to moderate Alzheimer’s disease.
Ihttps://www.cytodyn.com/newsroom/press-releases/detail/633/december-2024-letter-to-shareholders
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼